NCT00897520View on ClinicalTrials.gov

Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 14, 2008

Primary Completion Date

January 24, 2010

Study Completion Date

January 24, 2010

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

recombinant interferon alfa

GENETIC

proteomic profiling

OTHER

immunoenzyme technique

OTHER

laboratory biomarker analysis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

ECOG-ACRIN Cancer Research Group

NETWORK

NCT00897520 - Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy | Biotech Hunter | Biotech Hunter